Data / Drug companies / Dexamethasone sodium phosphate
Dexamethasone sodium phosphate: 25 companies and 97 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Dexamethasone sodium phosphate is listed in the FDA National Drug Code Directory by 25 companies, with 97 products in commercial distribution. 95 of the products (97.9%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, solution; injection; injection, emulsion, and the newest product started marketing on November 7, 2025.
The request: Get every company that lists dexamethasone sodium phosphate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 25
- Products
- 97
- Generic (ANDA) products
- 95 (97.9%)
- Application numbers
- 20
- Routes
- Intramuscular, Intravenous, Intra-articular, Intralesional, Soft tissue
- Brand names
- DMT Suik
- openFDA record search
- api.fda.gov
Companies that list dexamethasone sodium phosphate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Medical Purchasing Solutions, LLC | 13 | injection, solution; injection | Generic drugs (ANDA) | December 1, 2024 |
| Asclemed USA, Inc. | 8 | injection, solution; injection | Generic drugs (ANDA) | February 11, 2020 |
| HF Acquisition Co LLC, DBA HealthFirst | 7 | injection; injection, solution | Generic drugs (ANDA) | May 20, 2022 |
| Sportpharm LLC | 7 | injection, solution | Generic drugs (ANDA) | May 11, 2011 |
| Mylan Institutional LLC | 6 | injection, solution | Generic drugs (ANDA) | April 15, 2020 |
| A-S Medication Solutions | 5 | injection, solution; injection | Generic drugs (ANDA) | December 1, 2015 |
| Eugia US LLC | 5 | injection, solution; injection | Generic drugs (ANDA) | June 5, 2020 |
| Fresenius Kabi USA, LLC | 5 | injection, solution | Generic drugs (ANDA) | April 5, 2005 |
| Somerset Therapeutics, LLC | 5 | injection; injection, solution | Generic drugs (ANDA) | June 11, 2019 |
| Amneal Pharmaceuticals LLC | 4 | injection, solution | Generic drugs (ANDA) | August 27, 2018 |
| Fresenius Kabi USA, LLC | 4 | injection, solution; injection, emulsion | Generic drugs (ANDA) | February 21, 2024 |
| Gland Pharma Limited | 3 | injection | Generic drugs (ANDA) | September 25, 2023 |
| Henry Schein, Inc. | 3 | injection, solution; injection | Generic drugs (ANDA) | February 6, 2025 |
| Hikma Pharmaceuticals USA Inc. | 3 | injection | Generic drugs (ANDA) | September 7, 1982 |
| Remedyrepack Inc. | 3 | injection; injection, solution | Generic drugs (ANDA) | June 25, 2025 |
| Advanced Rx of Tennessee, LLC | 2 | injection; injection, solution | Generic drugs (ANDA) | November 7, 2025 |
| Asclemed USA Inc. | 2 | injection | Generic drugs (ANDA) | July 15, 1975 |
| Cardinal Health 107, LLC | 2 | injection; injection, solution | Generic drugs (ANDA) | September 7, 2000 |
| Civica, Inc. | 2 | injection | Generic drugs (ANDA) | November 13, 2019 |
| ProPharma Distribution | 2 | injection, solution | Generic drugs (ANDA) | May 11, 2011 |
| Sagent Pharmaceuticals | 2 | injection, solution | Generic drugs (ANDA) | December 1, 2024 |
| Armas Pharmaceuticals Inc. | 1 | injection, solution | Generic drugs (ANDA) | April 22, 2025 |
| Bausch & Lomb Incorporated | 1 | solution/ drops | Generic drugs (ANDA) | July 26, 1996 |
| Micro Labs Limited | 1 | injection, solution | Generic drugs (ANDA) | June 1, 2024 |
| Phlow Corporation | 1 | injection, solution | Generic drugs (ANDA) | December 15, 2021 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, solution | 63 | 64.9% |
| Injection | 31 | 32% |
| Injection, emulsion | 2 | 2.1% |
| Solution/ drops | 1 | 1% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 95 | 97.9% |
| Other unapproved drugs | 2 | 2.1% |
Pharmacologic classes
| Class | Products |
|---|---|
| Corticosteroid | 97 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.